Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering

Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering NEW YORK, NY, March 8, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced the pricing of its previously announced underwritten public offering of 569,560 shares […]